Nectar Life Sciences
Latest round
- Series A
Last raised
- Nov 2022
Total raised
- $32M
Investors
- 3
About Nectar Life Sciences
Founded in 2021 and based in New York, US, Nectar Life Sciences, Inc. operates as a healthcare platform that engages in determining possible allergies that could occur. Kenneth Chahine (CEO), Ben Oyler (COO), and Hersh Patel are the co-founders of the company. In November 2022, Nectar Life Sciences, Inc. The company provides a vertically integrated platform for allergens that includes a hybrid virtual and physical clinic model, a compounding pharmacy, a lab testing facility, and a network of allergist physicians to create customer experiences and align incentives. The firm also provides custom-formulated under-the-tongue drops. Nectar tests for different types of allergens such as grasses, trees, weeds, pets, molds, dust mites, and others. The startup generates revenue by selling indoor and outdoor allergy tests for USD 199 and monthly subscriptions to prescription allergy drops for USD 99.
Who invested in Nectar Life Sciences
3 investors across 2 rounds
See all investors in Nectar Life Sciences
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Nectar Life Sciences
Who invested in Nectar Life Sciences?
Nectar Life Sciences has 3 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Nectar Life Sciences raised?
Nectar Life Sciences has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Nectar Life Sciences last raise money?
Nectar Life Sciences's most recent round on record is a Series A, in Nov 2022.
What does Nectar Life Sciences do?
Founded in 2021 and based in New York, US, Nectar Life Sciences, Inc.
Where is Nectar Life Sciences headquartered?
Nectar Life Sciences is headquartered in New York, US.
Which VCs invest in companies like Nectar Life Sciences?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Kleiner Perkins and Lightspeed Venture Partners back healthcare companies at Nectar Life Sciences's stage. Their profiles are linked below.
VCs backing healthcare startups at Series A
Raising like Nectar Life Sciences? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.